Why Is GE HEALTHCARE TECHNO (GEHC) Stock Up Today?

GEHC stock rose 12.15% to $71.90 on July 29, 2026, driven by strong second-quarter results and updated guidance from the company. The firm reported adjusted earnings per share of $1.13, exceeding estimates, and reaffirmed its 2026 guidance. Record orders and a strategic review of its Patient Care Solutions unit added to the positive momentum.

What Happened

GE HealthCare Technologies Inc. delivered a second-quarter 2026 performance that exceeded expectations, with revenue of $5.30 billion, adjusted EBIT of $750 million, and adjusted EPS of $1.13, all above forecasts. The company reported a record backlog and strong order growth, despite divergent performance across its business segments. Management reaffirmed its 2026 adjusted EPS guidance of $4.80 to $5.00 and outlined a strategic review of its Patient Care Solutions unit. The results prompted BTIG to raise its price target to $79 and maintain a Buy rating. The stock’s sharp rise also followed a series of insider purchases and a recent uptick in congressional trading activity.

What The Data Shows

Over the last eight sessions, GEHC has gained 13.9%, rising from $63.14 to $71.90. The stock currently trades within its 52-week range of $58.75 to $89.77. The company’s fundamentals include a market cap of $27.8 billion, a P/E ratio of 15.4, and trailing twelve-month revenue growth of 6.0%. Recent insider transactions include three purchases totaling $805,000 in the last 90 days, with no sales reported. Congressional trades show six buys and six sells in the same period. The stock’s beta of 0.84 suggests it is less volatile than the broader market.

What To Watch

The company’s next key event will be its third-quarter 2026 earnings report, which is expected to provide further insight into its strategic review and operational performance. Investors should also monitor the breadth of coverage and any follow-up analyst ratings in the coming weeks.